R-1 (BioSeek Plc)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameR-1 (BioSeek Plc)
Drug Alias Name5HT 2b antagonist (Pharmagene)irritable bowel syndrome therapeutics (Pharmagene)PGN-1091PGN-1164R-1 (Asterand) +[7] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioseek Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioseek Llc
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A